<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Nordic Life Systems insights</title><link>https://www.nordiclifesystems.com/insights/</link><description>Market reports and B2B guides on protein, probiotics, postbiotics and EU rules.</description><language>en</language><atom:link href="https://www.nordiclifesystems.com/insights/feed.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1 and Protein 2026: What Brands Should Build</title><link>https://www.nordiclifesystems.com/insights/glp-1-protein-2026/</link><guid isPermaLink="true">https://www.nordiclifesystems.com/insights/glp-1-protein-2026/</guid><pubDate>Wed, 14 Oct 2026 08:00:00 +0000</pubDate><description>GLP-1 drugs are reshaping protein demand. The 2026 numbers, whey prices, product specs that work, and what EU rules allow on the label. A B2B guide.</description></item></channel></rss>
